EPISODE · Apr 14, 2021 · 45 MIN
34. Psilocybin vs Antidepressants with Dr Robin Carhart-Harris
from The Drug Science Podcast · host Drug Science
Robin Heads the Psychedelic Research Group within the Centre for Psychiatry at Imperial College London, where he has designed several functional brain imaging studies with psilocybin, LSD, MDMA and DMT, plus a clinical trial of psilocybin for treatment resistant depression. He has over 50 published papers in peer-reviewed scientific journals; two of which were ranked in the top 100 most impactful academic articles of 2016. Robin’s research has featured in major national and international media and he has given a popular TEDx talk.Does MDMA impact sleep?What does the brain look like under the influence of LSD?How do psychedelics change the quality of brain activity? Can psilocybin be used to treat depression? Psilocybin vs Escitalopram for Major Depressive Disorder Stanislav Grof LSD PsychotherapyRobin’s first paper – Waves of the Unconscious Amanda FeildingRobin’s PhD Drugs live – Channel 4Psilocybin LSD MDMADMTPsychedelic resting states The entropic brainHomological scaffolds of brain functional networksThe Stoned Ape theory DMT Neural Correlates of the DMT experience Psilocybin for Treatment-Resistant Depression Serotonin and brain function: a tale of two receptors ★ Support this podcast ★
Embed this episode
What this episode covers
Psilocybin is being heralded as a major breakthrough in the fight against depression, but how does it compare to the most effective treatment that doctors prescribe for depression? Find out, on the Drug Science Podcast with Dr Robin Carhart-Harris.
Ready to play
34. Psilocybin vs Antidepressants with Dr Robin Carhart-Harris
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.